Showing results (741-750 of 792) with videos related to
Sort By:
Pageof 80
The Lancet. Haematology|December 7, 2023
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working GroupNicolaus Kröger, Andrea Bacigalupo, Tiziano Barbui, et al.Blood|October 20, 2011
Risk factors for acute GVHD and survival after hematopoietic cell transplantationMadan Jagasia, Mukta Arora, Mary E D Flowers, et al.Nature Communications|May 8, 2014
Spider genomes provide insight into composition and evolution of venom and silkKristian W Sanggaard, Jesper S Bechsgaard, Xiaodong Fang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with MyelofibrosisRoni Tamari, Franck Rapaport, Nan Zhang, et al.Haematologica|September 17, 2013
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-ISrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.Nucleic Acids Research|November 18, 2022
The European Nucleotide Archive in 2022Josephine Burgin, Alisha Ahamed, Carla Cummins, et al.Communications Biology|February 16, 2022
Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol effluxIdit Dotan, Jiaqi Yang, Jiro Ikeda, et al.Blood Advances|May 13, 2024
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current eraAnand A Patel, James J Yoon, Hannah Johnston, et al.Blood|March 13, 2012
Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor eraErica Warlick, Kwang Woo Ahn, Tanya L Pedersen, et al.Bone Marrow Transplantation|March 26, 2021
Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaGeorgina Daher-Reyes, TaeHyung Kim, Igor Novitzky-Basso, et al.Pageof 80